Abstract
Asthma and COPD remain two diseases of the respiratory tract with unmet medical needs. This review considers the current state of play with respect to what is known about the underlying pathogenesis of these two chronic inflammatory diseases of the lung. The review highlights why they are different conditions requiring different approaches to treatment and provides a backdrop for the subsequent chapters in this volume discussing recent advances in the pharmacology and treatment of asthma and COPD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agusti A et al (2012) Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 7, e37483
Aikawa T et al (1992) Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 101(4):916–921
Amin K (2012) The role of mast cells in allergic inflammation. Respir Med 106:9–14
Barnes PJ (2008a) Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8:183–192
Barnes PJ (2008b) Cytokine networks in asthma and chronic obstructive pulmonary disease. J Clin Invest 118:3546–3556
Barnes PJ (2010) Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med 7, e1000220
Barnes PJ (2011) Pathophysiology of allergic inflammation. Immunol Rev 242(1):31–50
Barnes PJ (2012) Severe asthma: advances in current management and future therapy. J Allergy Clin Immunol 129(1):48–59
Barnes PJ (2013) Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 131:636–645
Barnes PJ (2014) Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 35:71–86
Barnes PJ (2015) Mechanisms of development of multimorbidity in the elderly. Eur Respir J 45:790–806
Barrecheguren M, Esquinas C, Miravitlles M (2015) The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med 21:74–79
Benayoun L et al (2003) Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 167(10):1360–1368
Bergeron C et al (2010) Airway remodelling in asthma: from benchside to clinical practice. Can Respir J 17(4):e85–e93
Bousquet J et al (2000) From Bronchoconstriction to airways inflammation and remodeling. Asthma 161(5):1720–1745
Brusasco V et al (1998) Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax 53:992–998
Brusselle GG, Joos GF, Bracke KR (2011) New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378:1015–1026
Caramori G et al (2011) Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax 66:521–527
Cookson W (1999) The alliance of genes and environment in asthma and allergy. Nature 402:5–11
Corren J (2013) Asthma phenotypes and endotypes: an evolving paradigm for classification. Discov Med 15(83):243–249
De Monchy JG et al (1985) Bronchoalveolar eosinophilia during allergen induced late asthmatic reactions. Am Rev Respir Dis 131(3):373–376
Deo SS et al (2010) Role played by Th2 cytokines in IgE mediated allergy and asthma. Lung India 27(2):66–71
Di Stefano A et al (2002) Increased expression of NF-kB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 20:556–563
Donnelly LE, Barnes PJ (2012) Defective phagocytosis in airways disease. Chest 141:1055–1062
Dusser DJ et al (1988) Airway neutral endopeptidase-like enzyme modulates tachykinin induced bronchoconstriction in vivo. J Appl Physiol 65:2385–2591
Elias JA et al (1999) Airway remodelling in asthma. J Clin Invest 104(8):1001–1006
Fahy JV (2015) Type 2 inflammation in asthma – present in most, absent in many. Nat Rev Immunol 15:57–65
Farmer SG et al (1990) Effects of epithelium removal on relaxation of airway smooth muscle induced by vasoactive intestinal peptide and electrical field stimulation. Br J Pharmacol 100:73–78
Fireman P (2003) Understanding asthma pathophysiology. Allergy Asthma Proc 24(2):79–83
Frossard N (2000) Role of bronchial smooth muscle in inflammation. Rev Mal Respir 17(2 pt 2):559–563
Galban CJ et al (2012) Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 18:1711–1715
George SN et al (2014) Human rhinovirus infection during naturally occurring COPD exacerbations. Eur Respir J 44:87–96
Grootendorst DC, Rabe KF (2004) Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 1:77–87
Guenette JA, Webb KA, O’Donnell DE (2012) Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J 40:322–329
Hara H et al (2013) Mitochondrial fragmentation in cigarette smoke-induced bronchial epithelial cell senescence. Am J Physiol Lung Cell Mol Physiol 305:L737–L746
Hershey G et al (1997) The association of atopy with a gain of function mutation in the a subunit of the IL-4 receptor. N Engl J Med 337:1720–1725
Hogg JC, Timens W (2009) The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 4:435–459
Holgate ST (2012) Innate and adaptive immune responses in asthma. Nat Med 18:673–683
Hurst JR et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363:1128–1138
Ito K, Barnes PJ (2009) COPD as a disease of accelerated lung aging. Chest 135:173–180
Ito K et al (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352:1967–1976
Janeway C (2001) Immunobiology: the immune system in health and disease, 5th edn. Garland Science, New York
Jeffery PK et al (2006) Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med 6:S5
Kirkham PA, Barnes PJ (2013) Oxidative stress in COPD. Chest 144:266–273
Kirkham PA et al (2011) Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of COPD. Am J Respir Crit Care Med 184:796–802
Lambrecht BN et al (2012) The airway epithelium in asthma. Nat Med 18(5):684–692
Leckie MJ et al (2000) Effects of an IL-5 blocking monoclonal antibody on eosinophils, airway hyper responsiveness and the late asthmatic response. Lancet 356(9248):2144–2148
Leikauf GD et al (1985) Bradykinin stimulates cl secretion and PGE2 release by canine tracheal epithelium. Am J Physiol 248:F48–F55
Lundgren R et al (1988) Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1(10):883–889
Madeo F, Zimmermann A, Maiuri MC, Kroemer G (2015) Essential role for autophagy in life span extension. J Clin Invest 125:85–93
Malhotra D et al (2008) Decline in NRF2 regulated antioxidants in COPD lungs due to loss of its positive regulator DJ-1. Am J Respir Crit Care Med 178:592–604
Manning PJ et al (1989) The effect of oral PGE2 on airway responsiveness in asthmatic subjects. Pulm Pharmacol 2:121–124
Matsuse H et al (2003) Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. Int Immunopharmacol 3:457–468
McAleer JP, Kolls JK (2014) Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev 260:129–144
McDonough JE et al (2011) Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365:1567–1575
Mercado N et al (2011) Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress. Biochem Biophys Res Commun 406:292–298
Mercado N, Ito K, Barnes PJ (2015) Accelerated ageing in chronic obstructive pulmonary disease: new concepts. Thorax 70:482–489
Mitani A, Ito K, Vuppusetty C, Barnes PJ, Mercado N (2015) Inhibition of mTOR restores corticosteroid sensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med
Mizumura K, Cloonan SM, Haspel JA, Choi AM (2012) The emerging importance of autophagy in pulmonary diseases. Chest 142:1289–1299
Mizumura K et al (2014) Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. J Clin Invest 124:3987–4003
Mukaro VR, Hodge S (2011) Airway clearance of apoptotic cells in COPD. Curr Drug Targets 12:460–468
Murdoch JR et al (2010) Chronic inflammation and asthma. Mutat Res 690:24–39
Nakamaru Y et al (2009) A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J 23:2810–2819
Nakanishi K (2010) Basophils are potent antigen presenting cells that selectively induce Th2 cells. Eur J Immunol 40:1836–1842
O’Byrne PM et al (2003) Airway hyperresponsiveness. Chest 123(3):411S–416S
O’Byrne PM et al (2011) Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med 183(5):589–595
Ortega HG et al (2014) Mepolizumab treated patients with severe eosinophilic asthma. N Engl J Med 371:1198–1207
Page C, Pitchford S (2014) Platelets and allergic inflammation. Clin Exp Allergy 44(7):901–913
Paschalaki KE et al (2013) Dysfunction of endothelial progenitor cells from smokers and COPD patients due to increased DNA damage and senescence. Stem Cells 31:2813–2826
Peacock JL et al (2011) Outdoor air pollution and respiratory health in patients with COPD. Thorax 66:591–596
Peinado VI, Pizarro S, Barbera JA (2008) Pulmonary vascular involvement in COPD. Chest 134:808–814
Pepe C et al (2005) Differences in airway remodelling between subjects with severe and moderate asthma. J Allergy Clin Immunol 116(3):544–549
Pitchford S (2007) Defining a role for platelets in allergic inflammation. Biochem Soc Trans 35(5):1104–1108
Postma DS, Rabe KF (2015) The asthma-COPD overlap syndrome. N Engl J Med 373:1241–1249
Renda T et al (2008) Increased activation of p38 MAPK in COPD. Eur Respir J 31:62–69
Rt A (2014) The role of ADP in platelet activation and its signalling in a Murine model of acute allergic inflammation. King’s College London, London, https://kclpure.kcl.ac.uk/portal/files/33809036/2014_Amison_Richard_1063150_ethesis.pdf
Seeger W et al (2013) Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol 62:D109–D116
Seemungal TA et al (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1418–1422
Seemungal T et al (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1618–1623
Singh R et al (2014) Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease. Respir Res 15:114
Sont JK et al (1996) Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51:496–502
Suissa S et al (2013) Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax 68:1029–1036
Taylor AE et al (2010) Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 35:1039–1047
Thomson NC et al (2008) Identification and management of adults with asthma prone to exacerbations: can we do better? BMC Pulm Med 8:27
van Schoor J et al (2005) Indirect bronchial hyperresponsiveness: the coming of age of a specific group of bronchial challenges. Clin Exp Allergy 35:250–261
Veen JCC et al (2000) Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 161:1902–1906
Wang YL et al (2008) Role of airway epithelial cells in development of asthma and allergic rhinitis. Respir Med 102(7):949–955
Wardlaw AJ et al (2000) Eosinophils in asthma and other allergic diseases. Br Med Bull 56:985–1003
Web.archive.org (2014) World Health Organisation | Asthma [online]. http://web.archive.org/web/20110629035454/http://www.who.int/mediacentre/factsheets/fs307/en/. Accessed 2 May 2016
Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370:786–796
Wedzicha JA, Brill SE, Allinson JP, Donaldson GC (2013) Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med 11:181
Wenzel SE et al (1997) Bronchoscopic evaluation of severe asthma, persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 156:737–743
Widdicombe JG (2003) Overview of neural pathways in allergy and asthma. Pulm Pharmacol Ther 16(1):23–30
Woisin FE et al (2001) Relationship of airway responsiveness with airway morphometry in normal and immunized rabbits. Pulm Pharmacol Ther 14:75–83
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Page, C., O’Shaughnessy, B., Barnes, P. (2016). Pathogenesis of COPD and Asthma. In: Page, C., Barnes, P. (eds) Pharmacology and Therapeutics of Asthma and COPD. Handbook of Experimental Pharmacology, vol 237. Springer, Cham. https://doi.org/10.1007/164_2016_61
Download citation
DOI: https://doi.org/10.1007/164_2016_61
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52173-2
Online ISBN: 978-3-319-52175-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)